HDAC2 and central nervous system cancer: The mRNA expression levels of HDAC1, HDAC2 and AKT1 were relatively high in glioma (Figure 4A, p < 0.05), while those of HDAC3 and HDAC6 have no significant difference between glioma and normal tissues (Supplementary Figure S1, p > 0.05).